Results 91 to 100 of about 27,896 (197)

Alpinia oxyphylla Miq.: Chemical Constituents, Neuroprotective and Metabolic Effects, and Translational Challenges—A Review of Preclinical Evidence

open access: yesFood Science &Nutrition, Volume 14, Issue 11, November 2026.
Alpinia oxyphylla Miq. (AOM), a medicinal and edible resource, contains diphenylheptanoids, polysaccharides, flavonoids, terpenoids, and phenolic acids. These constituents exert multi‐target synergistic effects by modulating neuroinflammation, oxidative stress, and the PI3K/Akt pathway, thereby improving Alzheimer's disease, Parkinson's disease, and ...
Ziyan Yang   +5 more
wiley   +1 more source

Brain‐Derived Neurotrophic Factor (BDNF), Estrogen Receptors, and Mossy Cells

open access: yesHippocampus, Volume 36, Issue 6, November 2026.
ABSTRACT Dentate gyrus (DG) function depends on the neurotrophin brain‐derived neurotrophic factor (BDNF) which shows robust synthesis in the principal cells, the granule cells (GCs). However, BDNF protein is present in the inner molecular layer (IML), where most afferents to GCs are from hilar mossy cells (MCs). Therefore, we asked whether MCs express
Chiara Criscuolo   +3 more
wiley   +1 more source

Curcumin in the Treatment of Various Diseases: Mechanism of Action, Bioavailability, Therapeutic Effects, and Current Clinical Trials

open access: yesMedComm, Volume 7, Issue 11, November 2026.
Curcumin, a naturally occurring polyphenol, exhibits significant anti‐inflammatory and antioxidant capabilities. This review elucidates the specific molecular mechanisms by which curcumin exerts therapeutic effects on various diseases, including neurological disorders, cardiovascular diseases, cancers, inflammatory disorders, and autoimmune diseases ...
Lin Wang   +15 more
wiley   +1 more source

Cancer Neuroscience: From Hallmark‐Enabling Biology to a Therapeutic Pillar

open access: yes
Advanced Oncology, Volume 1, Issue 1, December 2026.
Moran Amit
wiley   +1 more source

Neuropsychiatric symptom improvement and biomarker changes with electroacupuncture in adolescent and young adult cancer survivors: A randomized pilot trial

open access: yesPediatric, Adolescent &Young Adult Cancer, Volume 1, Issue 1, November 2026.
Abstract Introduction Electroacupuncture (EA) shows promise for managing neuropsychiatric symptoms, yet its role in adolescents and young adults (AYAs) living with cancer remains unclear. This is a randomized, controlled, patient‐blinded and assessor‐blinded pilot trial comparing two EA regimens to evaluate the improvement of neuropsychiatric symptoms ...
Alexandre Chan   +14 more
wiley   +1 more source

Protective Potentials of Natural Products Against Vascular Dementia: A Comprehensive Review of Experimental Studies

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6535-6552, November 2026.
ABSTRACT Vascular dementia (VaD), accounting for up to 20% of dementia cases globally, is primarily driven by chronic cerebral hypoperfusion (CCH), which leads to progressive cognitive impairment. Despite the increasing prevalence of VaD, effective treatments remain limited.
Jung‐Hoon Kim, Yongtaek Oh, Suin Cho
wiley   +1 more source

Lysergic Acid Diethylamide Induces Transcriptional Changes Opposing Signatures of Brain Ageing and Neurodegeneration

open access: yesAging Cell, Volume 25, Issue 11, November 2026.
Lysergic acid diethylamide (LSD) induces transcriptional programmes in the rodent prefrontal cortex that oppose signatures of human brain ageing and neurodegeneration. In primary cortical cultures, LSD also attenuates amyloid‐β‐induced alterations. Consistent with the signature reversion principle, these findings provide a data‐driven rationale for ...
Aurora Savino   +9 more
wiley   +1 more source

Subregion‐specific perineuronal net remodelling in the dorsal hippocampus drives vulnerability and resilience to chronic stress: The role of venlafaxine treatment

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 21, Page 6291-6305, November 2026.
Background and Purpose Neuronal plasticity enables the brain to adapt to internal and external demands by dynamically regulating synaptic connectivity and emotional circuitry. Impaired neuroplasticity represents a core pathophysiological framework of major depressive disorder, one of the leading causes of disability worldwide. Chronic stress is a major
Paola Brivio   +11 more
wiley   +1 more source

BDNF/TrkB Signaling and Epileptogenesis

open access: yes
Abstract The epilepsies are one of the most common neurologic disorders with a diversity of etiologies. Despite tremendous advances in both medical and surgical therapies, availability of preventive and disease-modifying therapies is an important unmet medical need.
Stephen C. Harward   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy